The conjugated linoleic acid isomer trans-9,trans-11 is a dietary occurring agonist of liver X receptor α

Biochemical and Biophysical Research Communications

Volumn 388, Issue 4, 2009, Pages 660-666

  Ecker, Josef ^a   Liebisch, Gerhard ^a   Patsch, Wolfgang ^b   Schmitz, Gerd ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CLA; Gene expression; LXR; Macrophages; Nuclear receptor

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; CONJUGATED LINOLEIC ACID; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ALPHA; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; SMALL INTERFERING RNA;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROSPRAY MASS SPECTROMETRY; FAT INTAKE; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; LIPID METABOLISM; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANS ISOMER; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

CELL LINE; DIET; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; LINOLEIC ACIDS, CONJUGATED; MACROPHAGES; ORPHAN NUCLEAR RECEPTORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; TRANSCRIPTION, GENETIC;

EID: 69949165386     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.048     Document Type: Article

References (33)

1. Tricon S., and Yaqoob P. Conjugated linoleic acid and human health: a critical evaluation of the evidence. Curr. Opin. Clin. Nutr. Metab. Care 9 (2006) 105-110
2. Ritzenthaler K.L., McGuire M.K., Falen R., Shultz T.D., Dasgupta N., and McGuire M.A. Estimation of conjugated linoleic acid intake by written dietary assessment methodologies underestimates actual intake evaluated by food duplicate methodology. J. Nutr. 131 (2001) 1548-1554
3. Pariza M.W., Park Y., and Cook M.E. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc. Soc. Exp. Biol. Med. 223 (2000) 8-13
4. Azizian H., and Kramer J.K. A rapid method for the quantification of fatty acids in fats and oils with emphasis on trans fatty acids using Fourier Transform near infrared spectroscopy (FT-NIR). Lipids 40 (2005) 855-867
5. Wallace R.J., McKain N., Shingfield K.J., and Devillard E. Isomers of conjugated linoleic acids are synthesized via different mechanisms in ruminal digesta and bacteria. J. Lipid Res. 48 (2007) 2247-2254
6. Ogawa J., Kishino S., Ando A., Sugimoto S., Mihara K., and Shimizu S. Production of conjugated fatty acids by lactic acid bacteria. J. Biosci. Bioeng. 100 (2005) 355-364
7. Coakley M., Johnson M.C., McGrath E., Rahman S., Ross R.P., Fitzgerald G.F., Devery R., and Stanton C. Intestinal bifidobacteria that produce trans-9, trans-11 conjugated linoleic acid: a fatty acid with antiproliferative activity against human colon SW480 and HT-29 cancer cells. Nutr. Cancer 56 (2006) 95-102
8. Loscher C.E., Draper E., Leavy O., Kelleher D., Mills K.H., and Roche H.M. Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J. Immunol. 175 (2005) 4990-4998
9. Schmitz G., and Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 47 (2008) 147-155
10. Moya-Camarena S.Y., Vanden Heuvel J.P., Blanchard S.G., Leesnitzer L.A., and Belury M.A. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J. Lipid Res. 40 (1999) 1426-1433
11. Ecker J., Langmann T., Moehle C., and Schmitz G. Isomer specific effects of conjugated linoleic acid on macrophage ABCG1 transcription by a SREBP-1c dependent mechanism. Biochem. Biophys. Res. Commun. 352 (2007) 805-811
12. Oram J.F., Lawn R.M., Garvin M.R., and Wade D.P. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275 (2000) 34508-34511
13. Gelissen I.C., Harris M., Rye K.A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan M., Kritharides L., and Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 534-540
14. Wang X., Collins H.L., Ranalletta M., Fuki I.V., Billheimer J.T., Rothblat G.H., Tall A.R., and Rader D.J. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117 (2007) 2216-2224
15. Yoshikawa T., Shimano H., Memiya-Kudo M., Yahagi N., Hasty A.H., Matsuzaka T., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Osuga J., Harada K., Gotoda T., Kimura S., Ishibashi S., and Yamada N. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 21 (2001) 2991-3000
16. Chawla A., Repa J.J., Evans R.M., and Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 294 (2001) 1866-1870
17. Repa J.J., and Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16 (2000) 459-481
18. Schmitz G., and Langmann T. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim. Biophys. Acta 1735 (2005) 1-19
19. Cao G., Beyer T.P., Yang X.P., Schmidt R.J., Zhang Y., Bensch W.R., Kauffman R.F., Gao H., Ryan T.P., Liang Y., Eacho P.I., and Jiang X.C. Phospholipid transfer protein is regulated by liver X receptors in vivo. J. Biol. Chem. 277 (2002) 39561-39565
20. Luo Y., and Tall A.R. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J. Clin. Invest. 105 (2000) 513-520
21. Joseph S.B., McKilligin E., Pei L., Watson M.A., Collins A.R., Laffitte B.A., Chen M., Noh G., Goodman J., Hagger G.N., Tran J., Tippin T.K., Wang X., Lusis A.J., Hsueh W.A., Law R.E., Collins J.L., Willson T.M., and Tontonoz P. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 99 (2002) 7604-7609
22. Mitro N., Mak P.A., Vargas L., Godio C., Hampton E., Molteni V., Kreusch A., and Saez E. The nuclear receptor LXR is a glucose sensor. Nature 445 (2007) 219-223
23. Oberkofler H., Schraml E., Krempler F., and Patsch W. Restoration of sterol-regulatory-element-binding protein-1c gene expression in HepG2 cells by peroxisome-proliferator-activated receptor-gamma co-activator-1alpha. Biochem. J. 381 (2004) 357-363
24. Schifferer R., Liebisch G., Bandulik S., Langmann T., Dada A., and Schmitz G. ApoA-I induces a preferential efflux of monounsaturated phosphatidylcholine and medium chain sphingomyelin species from a cellular pool distinct from HDL(3) mediated phospholipid efflux. Biochim. Biophys. Acta 1771 (2007) 853-863
25. Lampen A., Leifheit M., Voss J., and Nau H. Molecular and cellular effects of cis-9, trans-11-conjugated linoleic acid in enterocytes: effects on proliferation, differentiation, and gene expression. Biochim. Biophys. Acta 1735 (2005) 30-40
26. Beppu F., Hosokawa M., Tanaka L., Kohno H., Tanaka T., and Miyashita K. Potent inhibitory effect of trans9, trans11 isomer of conjugated linoleic acid on the growth of human colon cancer cells. J. Nutr. Biochem. 17 (2006) 830-836
27. Geyeregger R., Zeyda M., and Stulnig T.M. Liver X receptors in cardiovascular and metabolic disease. Cell. Mol. Life Sci. 63 (2006) 524-539
28. Yoshikawa T., Ide T., Shimano H., Yahagi N., Memiya-Kudo M., Matsuzaka T., Yatoh S., Kitamine T., Okazaki H., Tamura Y., Sekiya M., Takahashi A., Hasty A.H., Sato R., Sone H., Osuga J., Ishibashi S., and Yamada N. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha liver X receptor (LXR) in nutritional regulation of fatty acid metabolism: I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol. Endocrinol. 17 (2003) 1240-1254
29. Konig B., Koch A., Spielmann J., Hilgenfeld C., Stangl G.I., and Eder K. Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem. Pharmacol. 73 (2007) 574-585
30. Klopotek A., Hirche F., and Eder K. PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2. Exp. Biol. Med. (Maywood) 231 (2006) 1365-1372
31. Roche H.M., Noone E., Sewter C., Mc B.S., Savage D., Gibney M.J., O'Rahilly S., and Vidal-Puig A.J. Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha. Diabetes 51 (2002) 2037-2044
32. Levin N., Bischoff E.D., Daige C.L., Thomas D., Vu C.T., Heyman R.A., Tangirala R.K., and Schulman I.G. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 135-142
33. Ricote M., Valledor A.F., and Glass C.K. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 230-239